MN
Mentice AB (publ)
MNTC.ST · STO
13.75 kr +1.48% (+0.20 kr)
1M -2.83%
Market Cap 386.7M kr
P/E Ratio -
Div. Yield -
ROE 3.61%
Bulios Fair Price
11.64 kr
15.3% downside
Current Price
13.75 kr
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MNTC.ST is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
59 /100
Fair EV/EBITDA 17.99x
P/S 1.28x
P/B 3.13x
Growth
47 /100
Stable Rev. growth 8.59%
Book val. growth 5.24%
EPS growth N/A
Profitability
30 /100
Weak Gross margin 42.29%
Net margin 1.52%
Op. margin 2.87%
Quality
13 /100
Poor ROIC 28.93%
ROE 3.61%
ROA 1.54%
Debt
71 /100
Low Debt/Equity 0.11x
Current ratio 1.00x
Int. coverage -3.29x
Stability
39 /100
Moderate Beta 0.46x
Rev. volatility 14.95%
EPS volatility 337.71%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MNTC.ST
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Frans Matthieu Venker
Employees
109
Headquarters
Gothenburg
Upcoming events
10 NOV
Earnings
Upcoming earnings report